Recent

% | $
Quotes you view appear here for quick access.

Marina Biotech, Inc. Message Board

  • copphiggins copphiggins Jan 13, 2012 10:00 AM Flag

    I can see a Buy-out, actually

    I remember Merck bought Rosetta Bioinformatics or some such Seattle company just to incorporate their systems into Merck's reseach operation.

    Now any big pharma in a year or so - after RNA has had a major success somewhere (like Muscular Dystrophy, say) and becomes the Talk of the Town. Then you get the typical herd instict happening - such as was happening when Merck bought Sirna (from French) in the biggest RNA deal ever. (French and Sirna got the better of that deal, I'd say.)

    Now we are about to hit the next RNA plataeu higher and it would make even more sense now for a Merck to swoop in a second time and buy, not one simple technology like the did the last time, but rather a whole solar system of RNA technologies. And ones that are already showing promise in the clinic.

    Yes, it would make a lot of sense.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
MRNA
0.415+0.0140(+3.49%)Jul 29 3:17 PMEDT